...
首页> 外文期刊>Headache >Parenteral treatment of episodic tension-type headache. Is there sufficient evidence?
【24h】

Parenteral treatment of episodic tension-type headache. Is there sufficient evidence?

机译:肠外治疗发作性紧张型头痛。有足够的证据吗?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In their review article "Parenteral treatment of episodic tension-type headache: a systematic review," Weinman et al review 8 studies involving 486 patients and conclude that "various parenteral medications other than salicylates or nonsteroidals provide acute relief of tension type headache." The review article aims to discuss parenteral treatment of episodic tension-type headache (TTH) (2.1 in the International Classification of Headache), and not the treatment of chronic TTH (2.2). However, from the titles of 2 of the reviewed papers, it is obvious that chronic TTH was treated: (1) "The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache" and (2) "Effect of inhibition of nitric oxide synthase on chronic tension-type headache: A randomised crossover trial."
机译:Weinman等人在他们的综述文章“肠胃外治疗紧张型头痛:系统评价”中,对8项涉及486例患者的研究进行了综述,并得出结论:“除水杨酸盐或非甾体类药物外,各种肠胃外药物均可缓解紧张型头痛。”这篇综述文章旨在讨论发作性紧张型头痛(TTH)(国际头痛分类中的2.1)的肠胃外治疗,而不是慢性TTH的治疗(2.2)。但是,从2篇综述文章的标题中可以明显看出,已对慢性TTH进行了治疗:(1)“ 5-HT1激动剂舒马曲坦对慢性紧张型头痛具有显著作用”和(2)“有效一氧化氮合酶对慢性紧张型头痛的抑制作用:一项随机交叉试验。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号